Gonorrhea Therapeutics Market to be Worth Nearly US$ 2 Billion by 2027 - TMR

World News: . []

Albany, New York, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report on the gonorrhea therapeutics market for the forecast period of 2019–2027. According to the report, the global was valued at ~US$ 1.3 Bn in 2018 and is projected to expand at a from 2019 to 2027.

In terms of product, the global gonorrhea therapeutics market has been classified into uncomplicated gonococcal infection, gonococcal arthritis, gonococcal meningitis, and endocarditis. The segment dominated the global gonorrhea therapeutics market in 2018, and the trend is likely to continue during the forecast period.

The study presented here is based on a report by Transparency Market Research (TMR) titled “ - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027”.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

More news and information about Transparency Market Research

Published By:

Globe Newswire: 10:42 GMT Wednesday 11th September 2019

Published: .

Search for other references to "gonorrhea" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us